Skip to main content

COLLECTIVE FAMILY OFFICE LLC

Family Office

Position in IBRX — ImmunityBio, Inc.

CIK 1845066 YORK, PA

Position in IBRX

as of Jun 30, 2026 · filed Jul 2, 2026
Position Value
$1,376,286
+$206,558 QoQ
Shares Held
157,200
+3.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
2.81%
of 13F equity value
Holder Rank
#3
of 16 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Derivatives in IBRX

reported options exposure · as of Jun 30, 2025
CallValue
$26,400
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

COLLECTIVE FAMILY OFFICE LLC holds $2,011,290 across 2 Biotechnology names. IBRX ranks #1 (68.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IBRX
ImmunityBio, Inc.
This page
157,200 $1,376,286

All Filings in IBRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,376,286 157,200
2026-03-31 $1,169,728 152,507
2025-12-31 $310,523 156,830
2025-09-30 $396,748 161,280
2025-06-30 $375,883 142,380
2025-06-30 $26,400 10,000
2025-03-31 $313,551 104,170
2024-12-31 $227,404 88,830
2024-09-30 $40,920 11,000
2024-09-30 $295,230 79,363
2024-06-30 $444,643 70,355